Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Suzana Stojanovic-RundicClinic for Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-8680-4920
Mladen MarinkovicClinic for Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-8437-3493
Aleksandra StanojevicDepartment of Experimental Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-9179-2856
Dusica GavrilovicData Center, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.
Radmila JankovicDepartment of Experimental Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-2990-0523
Natasa MaksimovicInstitute of Epidemiology, University of Belgrade, 11000 Belgrade, Serbia.
Aleksandar TomasevicClinic for Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-2715-3504
Predrag PetrasinovicClinic for Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-6420-1122
Sandra RadenkovicClinic for Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.ORCID 0009-0002-1020-7331
Milena CavicDepartment of Experimental Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-7604-9295
Funding
Horizon Europe STEPUPIORS Project (HORIZON-WIDERA-2021-ACCESS-03, European Com-mission) Agreement No. 101079217The Ministry of Science, Technological Development and Innovation of the Republic of Serbia Agreement No. 451-03-66/2024-03/200043
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Dose Escalation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Short-Term Efficacy and Toxicity of VMAT-SIB vs. 3D-CRT. · full record | OpenQuestion